Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TORL-4500 by TORL Biotherapeutics for Solid Tumor: Likelihood of Approval
TORL-4500 is under clinical development by TORL Biotherapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
TORL-3600 by TORL Biotherapeutics for Solid Tumor: Likelihood of Approval
TORL-3600 is under clinical development by TORL Biotherapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
TORL-2307 by TORL Biotherapeutics for Pancreatic Cancer: Likelihood of Approval
TORL-2307 is under clinical development by TORL Biotherapeutics and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
TORL-2307 by TORL Biotherapeutics for Gastric Cancer: Likelihood of Approval
TORL-2307 is under clinical development by TORL Biotherapeutics and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
TORL-2307 by TORL Biotherapeutics for Solid Tumor: Likelihood of Approval
TORL-2307 is under clinical development by TORL Biotherapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...